VIDEO: Top breast cancer studies scheduled for presentation at ASCO

ByStephanie Graff, MD

Stephanie L. Graff, MD, FACP, spoke with Healio about the breast cancer-focused sessions she is most excited to attend at the ASCO Annual Meeting, taking place June 3-7 in Chicago.

“Practice changing in breast oncology should be DESTINY-Breast04, changing the definition of breast cancer with a new look at HER2-low breast cancer in the metastatic breast cancer space with trastuzumab deruxtecan [Enhertu; Daiichi Sankyo, AstraZeneca],” said Graff, director of the breast oncology program at Lifespan Cancer Institute and assistant professor of medicine at Brown Alpert Medical School.

Graff also is looking forward to a presentation on the phase 3 data from the TROPiCS-02 study and OS data from the PALOMA-2 study, along with other data such as a first look at results from the MAINTAIN study, among others.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures: Healio was unable to confirm relevant financial disclosures at the time of publication.

Women in Oncology

Read more

VIDEO: Top breast cancer studies scheduled for presentation at ASCO

Related Content